Finance

Beta
Lists
TMDX:NASDAQ
TransMedics Group Inc
$70.15
-9.77%
(-7.60) 1D
Jun 26, 12:13:16 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TMDX...
Open
$74.50
High
$74.50
Low
$67.05
Mkt. cap
2.43B
Avg. vol.
1.21M
Volume
1.49M
P/E ratio
16.14
52-wk high
$156.00
52-wk low
$60.10
EPS
$4.36
Beta
1.91
Shares outstanding
34.56M
No. of employees
898
Open
$74.50
High
$74.50
Low
$67.05
Mkt. cap
2.43B
Avg. vol.
1.21M
Volume
1.49M
P/E ratio
16.14
52-wk high
$156.00
52-wk low
$60.10
EPS
$4.36
Beta
1.91
Shares outstanding
34.56M
No. of employees
898
News stories
From sources across the web
About TransMedics Group Inc
CEO-
Employees898
Founded1998
HeadquartersAndover, Massachusetts, United States
SectorMedical device
Websitetransmedics.com
Analyst ratings
Based on 9 analysts giving stock ratings to TMDX in the past 3 months
Buy
Buy
6
Hold
3
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for TMDX in the last 3 months.
Highest
Current $70.15
$175.00 (+149.47%)
Average
$120.25 (+71.42%)
Lowest
$63.00 (-10.19%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Stephan
Stifel Nicolaus
Hold
Maintained
$80.00
+14%
06/26/2026
William Plovanic
Canaccord Genuity
Buy
Maintained
$124.00
+76.8%
06/09/2026
Michael Matson
Needham
Buy
Maintained
$142.00
+102.4%
06/09/2026
Ryan Daniels
William Blair
Buy
Maintained
-
-
06/05/2026
Rob Owens
Piper Sandler
Hold
Reiterated
$63.00
-10.2%
06/02/2026
Matthew O'Brien
Piper Sandler
Hold
Reiterated
$63.00
-10.2%
06/02/2026
Josh Jennings
TD Cowen
Buy
Maintained
$120.00
+71.1%
05/13/2026
Suraj Kalia
Oppenheimer
Hold
Downgraded
$175.00
+149.5%
05/06/2026
David Rescott
Robert W. Baird
Buy
Maintained
$140.00
+99.6%
05/06/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
$118.00
+68.2%
04/06/2026
Allen Gong
J.P. Morgan
Hold
Maintained
$149.00
+112.4%
02/25/2026
Patrick Wood
Morgan Stanley
Hold
Maintained
$135.00
+92.4%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
157.37M
143.82M
160.76M
173.93M
Cost of goods sold
60.78M
59.25M
67.35M
72.77M
Cost of revenue
60.78M
59.25M
67.35M
72.77M
Research and development expenses
15.93M
15.26M
20.70M
24.88M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.09M
46.02M
51.44M
62.98M
Operating expense
60.02M
61.28M
72.14M
87.86M
Total operating expenses
120.80M
120.52M
139.49M
160.64M
Operating income
36.57M
23.30M
21.27M
13.30M
Other non operating income
-9.00K
22.00K
2.41M
258.00K
EBT including unusual items
36.18M
23.03M
21.63M
8.48M
EBT excluding unusual items
36.18M
23.03M
21.63M
8.48M
Income tax expense
1.28M
-1.29M
-83.75M
1.17M
Effective tax rate
3.52%
-5.59%
-387.14%
13.79%
Other operating expenses
-
-
-
-
Net income
34.91M
24.32M
105.38M
7.32M
Net profit margin
22.18%
16.91%
65.55%
4.21%
Earnings per share
0.92
0.66
0.53
0.30
Interest and investment income
2.50M
3.30M
3.30M
2.70M
Interest expense
-3.48M
-3.49M
-3.35M
-7.17M
Net interest expenses
-976.00K
-191.00K
-54.00K
-4.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
43.30M
29.35M
28.24M
24.46M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of TMDX
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer